首页> 外文OA文献 >Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides.
【2h】

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides.

机译:Cathelicidin宿主防御肽抑制慢病毒复制周期的早期步骤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: The antibacterial activity of host defense peptides (HDP) is largely mediated by permeabilization of bacterial membranes. The lipid membrane of enveloped viruses might also be a target of antimicrobial peptides. Therefore, we screened a panel of naturally occurring HDPs representing different classes for inhibition of early, Env-independent steps in the HIV replication cycle. A lentiviral vector-based screening assay was used to determine the inhibitory effect of HDPs on early steps in the replication cycle and on cell metabolism. RESULTS: Human LL37 and porcine Protegrin-1 specifically reduced lentiviral vector infectivity, whereas the reduction of luciferase activities observed at high concentrations of the other HDPs is primarily due to modulation of cellular activity and/ or cytotoxicity rather than antiviral activity. A retroviral vector was inhibited by LL37 and Protegrin-1 to similar extent, while no specific inhibition of adenoviral vector mediated gene transfer was observed. Specific inhibitory effects of Protegrin-1 were confirmed for wild type HIV-1. CONCLUSION: Although Protegrin-1 apparently inhibits an early step in the HIV-replication cycle, cytotoxic effects might limit its use as an antiviral agent unless the specificity for the virus can be improved.
机译:背景:宿主防御肽(HDP)的抗菌活性在很大程度上由细菌膜的透化作用介导。包膜病毒的脂膜也可能是抗菌肽的靶标。因此,我们筛选了代表不同类别的一组天然存在的HDP,以抑制HIV复制周期中与Env无关的早期步骤。基于慢病毒载体的筛选测定用于确定HDP对复制周期的早期步骤和细胞代谢的抑制作用。结果:人LL37和猪Protegrin-1特异性降低了慢病毒载体的感染性,而在其他HDP高浓度下观察到的萤光素酶活性的降低主要是由于细胞活性和/或细胞毒性而不是抗病毒活性的调节。逆转录病毒载体被LL37和Protegrin-1抑制的程度相似,而未观察到对腺病毒载体介导的基因转移的特异性抑制。已证实Protegrin-1对野生型HIV-1具有特异性抑制作用。结论:尽管Protegrin-1显然抑制了HIV复制周期的早期阶段,但除非能够提高对病毒的特异性,否则细胞毒作用可能会限制其作为抗病毒剂的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号